Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. (Q34633758)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. |
scientific article |
Statements
1 reference
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. (English)
1 reference
Oyvind S Bruland
1 reference
Sten Nilsson
1 reference
Lars Franzén
1 reference
Christopher Parker
1 reference
Christopher Tyrrell
1 reference
René Blom
1 reference
Jan Tennvall
1 reference
Bo Lennernäs
1 reference
Ulf Petersson
1 reference
Dag C Johannessen
1 reference
Michael Sokal
1 reference
Katharine Pigott
1 reference
Jeffrey Yachnin
1 reference
Michael Garkavij
1 reference
Peter Strang
1 reference
Johan Harmenberg
1 reference
Bjørg Bolstad
1 reference
1 reference
Identifiers
1 reference